FOR SOPHISTICATED INVESTORS
Park Vale Capital is currently focusing on Biotechnology investments in companies engaged in Late Stage Biotechnology and Pharma development selected from their extensive network of deal flow working together with F2 Capital Ltd.
Hudson Fairfax Group ("HFG") is a New York-based independent financial sponsor and business development team specializing in private equity investments and sales acceleration in cyber security, intelligence, networks, space, and defence companies. In 2013, Hudson Fairfax joined forces with Park Vale Capital.
The China Special Situations strategy is led by Greg Ritchie, Bin Yu and Tony Holmes through our affiliated company LVF Capital.
The Real Estate Opportunities strategy is led by Rod Priestley and Greg Ritchie, enabling investors to utilise the experience of specialist teams to deliver development and investment properties.
Adaptive Strategies. Park Vale has designed an investment strategy to provide low volatility and low correlation performance from the liquid financial markets. The principals of the Adaptive Strategies team have developed and managed a series of liquid trading investment strategies applying machine learning in the form of evolutionary technology and adaptive quantitative modelling to invest in a variety of highly liquid financial markets with varying risk/return parameters..
The New Technologies strategy has enabled Park Vale to invest and develop companies with proven transformational technology and to develop their markets globally, especially bringing material benefits such that this large and important marketplace can be part of the thought in which leaders driving global change can improve how we approach our daily lifestyles.
JABCAP (LUX) is an investment company with variable capital, structured as an umbrella fund with segregated liability between sub-funds incorporated under the laws of the Grand Duchy of Luxembourg. JABCAP (LUX) has a number of different sub-funds. The assets and liabilities of each fund are segregated by law.